» Articles » PMID: 32426546

Tualang Honey Supplementation As Cognitive Enhancer in Patients with Schizophrenia

Overview
Journal Heliyon
Specialty Social Sciences
Date 2020 May 20
PMID 32426546
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Schizophrenia is a chronic mental illness with clusters of symptoms, including cognitive impairment. This study aimed to explore the effect of Tualang Honey (TH) on cognitive domains, especially as it pertained to the verbal memory of schizophrenia patients.

Method: This was a cross-sectional study involved 80 individuals, diagnosed with schizophrenia. The Malay Version Auditory Verbal Learning Test (MVAVLT) was used. Data were analysed using SPSS 20.0 software. Intention to treat analysis was applied.

Result: A comparison of the total learning score at eight weeks between the two groups based on time effect and time-treatment interaction favoured TH group.

Conclusion: This study concludes that by supplementing schizophrenia patients with 8-week of TH did improve total learning performance across domains in the immediate memory among patients with schizophrenia.

Citing Articles

Medicinal activities of Tualang honey: a systematic review.

Azman A, Tan J, Abdullah M, Bahari H, Lim V, Yong Y BMC Complement Med Ther. 2024; 24(1):358.

PMID: 39367403 PMC: 11453070. DOI: 10.1186/s12906-024-04664-2.


Geographical Origin Authentication-A Mandatory Step in the Efficient Involvement of Honey in Medical Treatment.

Magdas T, David M, Hategan A, Filip G, Magdas D Foods. 2024; 13(4).

PMID: 38397509 PMC: 10887874. DOI: 10.3390/foods13040532.


Polyherbal Combinations Used by Traditional Health Practitioners against Mental Illnesses in Bamako, Mali, West Africa.

Moussavi N, Mounkoro P, Dembele S, Ballo N, Togola A, Diallo D Plants (Basel). 2024; 13(3).

PMID: 38337987 PMC: 10857219. DOI: 10.3390/plants13030454.


Honey on brain health: A promising brain booster.

Zamri N, Ghani N, Ismail C, Zakaria R, Shafin N Front Aging Neurosci. 2023; 14:1092596.

PMID: 36733498 PMC: 9887050. DOI: 10.3389/fnagi.2022.1092596.


Neuroprotective Natural Products' Regulatory Effects on Depression via Gut-Brain Axis Targeting Tryptophan.

Liaqat H, Parveen A, Kim S Nutrients. 2022; 14(16).

PMID: 36014776 PMC: 9413544. DOI: 10.3390/nu14163270.


References
1.
Siuda J, Patalong-Ogiewa M, Zmuda W, Targosz-Gajniak M, Niewiadomska E, Matuszek I . Cognitive impairment and BDNF serum levels. Neurol Neurochir Pol. 2017; 51(1):24-32. DOI: 10.1016/j.pjnns.2016.10.001. View

2.
Abdel-Hamid M, Lehmkamper C, Sonntag C, Juckel G, Daum I, Brune M . Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions. Psychiatry Res. 2008; 165(1-2):19-26. DOI: 10.1016/j.psychres.2007.10.021. View

3.
Schliebs R, Arendt T . The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2010; 221(2):555-63. DOI: 10.1016/j.bbr.2010.11.058. View

4.
Forbes N, Carrick L, McIntosh A, Lawrie S . Working memory in schizophrenia: a meta-analysis. Psychol Med. 2008; 39(6):889-905. DOI: 10.1017/S0033291708004558. View

5.
Deiana S, Platt B, Riedel G . The cholinergic system and spatial learning. Behav Brain Res. 2010; 221(2):389-411. DOI: 10.1016/j.bbr.2010.11.036. View